| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).
|
Eur Heart J
|
2009
|
14.06
|
|
2
|
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2013
|
12.73
|
|
3
|
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
|
Eur J Heart Fail
|
2012
|
10.38
|
|
4
|
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
|
Eur Heart J
|
2013
|
9.54
|
|
5
|
Fibrinolysis for patients with intermediate-risk pulmonary embolism.
|
N Engl J Med
|
2014
|
9.33
|
|
6
|
Sildenafil citrate therapy for pulmonary arterial hypertension.
|
N Engl J Med
|
2005
|
9.27
|
|
7
|
Third universal definition of myocardial infarction.
|
J Am Coll Cardiol
|
2012
|
8.59
|
|
8
|
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
|
Eur Heart J
|
2014
|
6.32
|
|
9
|
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
|
Eur Heart J
|
2013
|
6.17
|
|
10
|
Diagnosis and assessment of pulmonary arterial hypertension.
|
J Am Coll Cardiol
|
2009
|
5.31
|
|
11
|
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
|
Eur Heart J
|
2015
|
5.24
|
|
12
|
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
|
Eur Heart J
|
2013
|
5.23
|
|
13
|
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
|
N Engl J Med
|
2013
|
4.98
|
|
14
|
Diagnosis and differential assessment of pulmonary arterial hypertension.
|
J Am Coll Cardiol
|
2004
|
3.63
|
|
15
|
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.
|
Eur Heart J
|
2004
|
3.51
|
|
16
|
Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.
|
Circulation
|
2013
|
2.82
|
|
17
|
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
|
Chest
|
2006
|
2.43
|
|
18
|
Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism.
|
Chest
|
2003
|
2.40
|
|
19
|
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
|
Hum Mutat
|
2006
|
2.30
|
|
20
|
Management of grown up congenital heart disease.
|
Eur Heart J
|
2003
|
1.94
|
|
21
|
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.
|
Circulation
|
2011
|
1.92
|
|
22
|
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
|
J Am Coll Cardiol
|
2009
|
1.78
|
|
23
|
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.
|
J Am Coll Cardiol
|
2002
|
1.77
|
|
24
|
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.
|
Am J Respir Crit Care Med
|
2002
|
1.72
|
|
25
|
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
|
J Am Coll Cardiol
|
2008
|
1.69
|
|
26
|
Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension.
|
Chest
|
2007
|
1.66
|
|
27
|
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era.
|
Eur Respir J
|
2012
|
1.63
|
|
28
|
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.
|
J Am Coll Cardiol
|
2003
|
1.62
|
|
29
|
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.
|
Rev Esp Cardiol (Engl Ed)
|
2016
|
1.61
|
|
30
|
Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
|
Chest
|
2004
|
1.60
|
|
31
|
Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia.
|
Circulation
|
2009
|
1.50
|
|
32
|
'Syringe-in-the-pocket'--a new approach to the outpatient thromboembolic prophylaxis of recurrent atrial fibrillation.
|
Cardiology
|
2007
|
1.39
|
|
33
|
End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives.
|
J Am Coll Cardiol
|
2004
|
1.24
|
|
34
|
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension.
|
Eur Respir J
|
2012
|
1.11
|
|
35
|
Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism.
|
Am J Cardiol
|
2002
|
1.06
|
|
36
|
Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension.
|
Chest
|
2012
|
0.98
|
|
37
|
Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension.
|
Kardiol Pol
|
2008
|
0.91
|
|
38
|
Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction.
|
Eur Heart J
|
2007
|
0.89
|
|
39
|
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2016
|
0.88
|
|
40
|
Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
|
Kardiol Pol
|
2003
|
0.87
|
|
41
|
[Guidelines on the diagnosis and management of acute pulmonary embolism].
|
G Ital Cardiol (Rome)
|
2009
|
0.87
|
|
42
|
Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT.
|
Ann Transplant
|
2007
|
0.85
|
|
43
|
Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension.
|
Pulm Pharmacol Ther
|
2011
|
0.84
|
|
44
|
[Polish forum for prevention guidelines on cardiovascular risk assessment].
|
Kardiol Pol
|
2007
|
0.84
|
|
45
|
[Value of spiral computed tomography in pulmonary hypertension].
|
Pol Arch Med Wewn
|
2004
|
0.83
|
|
46
|
[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update].
|
Pol Arch Med Wewn
|
2012
|
0.81
|
|
47
|
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
|
2016
|
0.81
|
|
48
|
Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?
|
Heart Vessels
|
2006
|
0.80
|
|
49
|
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.
|
Kardiol Pol
|
2013
|
0.80
|
|
50
|
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update].
|
Pol Arch Med Wewn
|
2009
|
0.79
|
|
51
|
[Recurrent effusive pericarditis in the course of adult-onset Still's disease--case reports of two patients].
|
Pneumonol Alergol Pol
|
2011
|
0.78
|
|
52
|
[Neoplastic pericarditis--the role of different diagnostic procedures].
|
Pol Arch Med Wewn
|
2006
|
0.78
|
|
53
|
Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study.
|
Thromb Haemost
|
2013
|
0.78
|
|
54
|
In search of markers of treatment failure and poor prognosis in IPAH - the value of mosaic lung attenuation pattern on thin-section CT scans.
|
Multidiscip Respir Med
|
2010
|
0.78
|
|
55
|
Factors determining long-term maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation.
|
Kardiol Pol
|
2003
|
0.77
|
|
56
|
[Guidelines on diagnosis and treatment of pulmonary arterial hypertension].
|
Rev Esp Cardiol
|
2005
|
0.77
|
|
57
|
In-hospital major bleeding predicts mortality in patients with pulmonary embolism: an analysis of ZATPOL Registry data.
|
Int J Cardiol
|
2013
|
0.77
|
|
58
|
Summary of recommendations for the haemodynamic and angiographic assessment of the pulmonary circulation. Joint statement of the Polish Cardiac Society's Working Group on Pulmonary Circulation and Association of Cardiovascular Interventions.
|
Kardiol Pol
|
2015
|
0.77
|
|
59
|
[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].
|
Kardiol Pol
|
2015
|
0.77
|
|
60
|
[Normal D-dimer concentration in hospitalized patients with lung diseases].
|
Pneumonol Alergol Pol
|
2012
|
0.77
|
|
61
|
Myoglobin stratifies short-term risk in acute major pulmonary embolism.
|
Clin Chim Acta
|
2003
|
0.77
|
|
62
|
[Abnormalities in high-resolution computed tomography of the lungs in patients with idiopathic pulmonary arterial hypertension -- correlation with hemodynamic parameters and prognostic significance].
|
Pneumonol Alergol Pol
|
2009
|
0.76
|
|
63
|
Left main artery compression by pulmonary artery aneurysm and ostial athero-stenosis of left anterior descending artery in a young female with pulmonary arterial hypertension.
|
Eur Heart J
|
2012
|
0.76
|
|
64
|
A decrease of enlarged left atrium following cardioversion of atrial fibrillation predicts the long-term maintenance of sinus rhythm.
|
Kardiol Pol
|
2005
|
0.76
|
|
65
|
Polish Forum for Prevention: a response to the European Society of Cardiology 'call for action' in Poland.
|
Eur J Cardiovasc Prev Rehabil
|
2010
|
0.75
|
|
66
|
The recurrence after ten years - "mother in-law variant" of tako-tsubo syndrome.
|
Kardiol Pol
|
2010
|
0.75
|
|
67
|
Cardiac troponins in acute pulmonary embolism.
|
Chest
|
2002
|
0.75
|
|
68
|
[Advances in pulmonology in year 2012].
|
Pneumonol Alergol Pol
|
2013
|
0.75
|
|
69
|
Severity of arterial and chronic thromboembolic pulmonary hypertension is associated with impairment of heart rate turbulence.
|
Ann Noninvasive Electrocardiol
|
2014
|
0.75
|
|
70
|
[Vascular complications in a 51-year-old female with a primary antiphospholipd syndrome--a case report].
|
Kardiol Pol
|
2007
|
0.75
|
|
71
|
[Differential diagnosis of pneumonia and pulmonary embolism].
|
Pneumonol Alergol Pol
|
2002
|
0.75
|
|
72
|
[Role of echocardiography in monitoring of cardiac toxicity of cancer pharmacotherapy. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging].
|
Kardiol Pol
|
2014
|
0.75
|
|
73
|
[A case of a patient with idiopathic pulmonary arterial hypertension treated with lung transplantation: a "bumpy road" to success].
|
Pol Arch Med Wewn
|
2006
|
0.75
|
|
74
|
[Chest ultrasound in the diagnosis of pulmonary embolism in a pregnant patient - a case report].
|
Pneumonol Alergol Pol
|
2009
|
0.75
|
|
75
|
[Thrombo-embolic pulmonary hypertension--do not spoil a chance for effective surgery!].
|
Kardiol Pol
|
2011
|
0.75
|
|
76
|
[Feasibility of home self-administration of low molecular weight heparin by patients with atrial fibrillation recurrence. A new approach to thromboembolic prophyllaxis].
|
Pol Arch Med Wewn
|
2005
|
0.75
|
|
77
|
[Pulmonary thromboembolism as a late complication of mitochondrial myopathy (Kearns-Sayer syndrome ].
|
Pneumonol Alergol Pol
|
2003
|
0.75
|
|
78
|
Functional class and type of pulmonary hypertension determinate severity of cardiac autonomic dysfunction assessed by heart rate variability and turbulence.
|
Acta Cardiol
|
2015
|
0.75
|
|
79
|
Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single centre European experience.
|
Kardiol Pol
|
2017
|
0.75
|
|
80
|
Improvement in Quality of Life and Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension Treated With Balloon Pulmonary Angioplasty.
|
Circ J
|
2017
|
0.75
|
|
81
|
Centrilobular nodules in high resolution computed tomography of the lung in IPAH patients - preliminary data concerning clinico-radiological correlates.
|
Pneumonol Alergol Pol
|
2016
|
0.75
|
|
82
|
[2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines].
|
Kardiol Pol
|
2016
|
0.75
|
|
83
|
[Interstitial pneumonitis in a patient treated with amiodarone -- case report].
|
Pneumonol Alergol Pol
|
2008
|
0.75
|
|
84
|
[Pulmonary thrombendarterectomy in a patient with chronic thromboembolic pulmonary hypertension (CTEPH) and chronic renal failure due to diabetic nephropathy--case report].
|
Pol Arch Med Wewn
|
2004
|
0.75
|
|
85
|
[Wegener's granulomatosis presenting with ischaemic stroke].
|
Pneumonol Alergol Pol
|
2008
|
0.75
|
|
86
|
[Mycobacterium kansasii infection in chronic thromboembolic pulmonary hypertension (CTEPH), report of two cases].
|
Pneumonol Alergol Pol
|
2004
|
0.75
|
|
87
|
Contemporary methods for the treatment of pulmonary embolism - is it prime-time for percutaneous interventions?
|
Kardiol Pol
|
2017
|
0.75
|
|
88
|
[Acquired methemoglobinemia--case report].
|
Pneumonol Alergol Pol
|
2010
|
0.75
|
|
89
|
Primary Sjögren's Syndrome with two extraglandular sites involvement - case report.
|
Pneumonol Alergol Pol
|
2010
|
0.75
|
|
90
|
[Diagnostic difficulties in primary mesothelioma].
|
Pneumonol Alergol Pol
|
2004
|
0.75
|
|
91
|
[A statement the Polish Cardiac Society Working Group on Pulmonary Circulation on screening for CTEPH patients after acute pulmonary embolism].
|
Kardiol Pol
|
2017
|
0.75
|
|
92
|
[Effect of long-term therapy with oral Beraprost on survival of patients with arterial and inoperable thromboembolic pulmonary hypertension].
|
Pol Arch Med Wewn
|
2004
|
0.75
|
|
93
|
[Right ventricle structure and function in patients with obstructive sleep apnea (OSA)].
|
Pol Arch Med Wewn
|
2004
|
0.75
|
|
94
|
The "bouncing" catheter.
|
Cardiol J
|
2016
|
0.75
|
|
95
|
[Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
|
Pol Arch Med Wewn
|
2002
|
0.75
|
|
96
|
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
|
Eur J Vasc Endovasc Surg
|
2017
|
0.75
|
|
97
|
Non-tuberculous mycobacterial lung disease (NT MLD ) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension.
|
Pneumonol Alergol Pol
|
2014
|
0.75
|
|
98
|
[Effect of localization of pulmonary arterial changes on echocardiographic indices of right heart function and their correlation with exercise capacity: comparison of arterial and thromboembolic pulmonary hypertension].
|
Pol Arch Med Wewn
|
2004
|
0.75
|
|
99
|
Atrial septostomy for severe primary pulmonary hypertension - report on two cases.
|
Kardiol Pol
|
2003
|
0.75
|
|
100
|
[Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology].
|
Turk Kardiyol Dern Ars
|
2014
|
0.75
|
|
101
|
Vena cava superior stenting for rescue treatment of critical stenosis related to progressing cancer disease.
|
Kardiol Pol
|
2016
|
0.75
|
|
102
|
[Infective endocarditis in a patient with multiple myeloma. A case report].
|
Kardiol Pol
|
2005
|
0.75
|
|
103
|
[Pulmonary embolism in course of deep vein thrombosis of lower extremities in patient wit bilateral femoral bone fracture after car accident injuries].
|
Pneumonol Alergol Pol
|
2002
|
0.75
|
|
104
|
[Lung transplantation for end-stage pulmonary hypertension].
|
Pol Arch Med Wewn
|
2004
|
0.75
|
|
105
|
[Medical treatment in chronic thromboembolic pulmonary hypertension].
|
Kardiol Pol
|
2010
|
0.75
|
|
106
|
Low DLCO in idiopathic pulmonary arterial hypertension - clinical correlates and prognostic significance.
|
Pneumonol Alergol Pol
|
2016
|
0.75
|
|
107
|
[Clinical course of familial primary pulmonary hypertension in a 39-year-old female and her two children].
|
Kardiol Pol
|
2009
|
0.75
|
|
108
|
[Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension].
|
Pol Arch Med Wewn
|
2004
|
0.75
|
|
109
|
[Autoimmune thyroid diseases in patients with primary pulmonary hypertension].
|
Pneumonol Alergol Pol
|
2004
|
0.75
|
|
110
|
[Unusual cause of right heart failure decompensation in 21-years old patient with idiopathic pulmonary arterial hypertension -- a case report].
|
Pneumonol Alergol Pol
|
2007
|
0.75
|
|
111
|
[Statement on the diagnosis and treatment of tobacco dependence in patients with cardiovascular diseases].
|
Kardiol Pol
|
2011
|
0.75
|
|
112
|
[Constrictive pericarditis as complication of viral respiratory infection].
|
Kardiol Pol
|
2012
|
0.75
|
|
113
|
Polish forum for prevention guidelines on cardiovascular diseases prevention in women.
|
Kardiol Pol
|
2007
|
0.75
|
|
114
|
Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report.
|
Adv Respir Med
|
2017
|
0.75
|
|
115
|
[Pulmonary hypertension in contemporary imaging. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging].
|
Kardiol Pol
|
2014
|
0.75
|
|
116
|
Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases.
|
Kardiol Pol
|
2007
|
0.75
|
|
117
|
[Scimitar syndrome--case report].
|
Pol Arch Med Wewn
|
2004
|
0.75
|